Find Lotamilast manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Lotamilast, 947620-48-6, E6005, E-6005, Rvt-501, Lotamilast [usan]
Molecular Formula
C26H24N4O5
Molecular Weight
472.5  g/mol
InChI Key
BBTFKAOFCSOZMB-UHFFFAOYSA-N
FDA UNII
TO043KKB9C

Lotamilast
E6005 has been used in trials studying the treatment of Atopic Dermatitis.
1 2D Structure

Lotamilast

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
methyl 4-[[3-[6,7-dimethoxy-2-(methylamino)quinazolin-4-yl]phenyl]carbamoyl]benzoate
2.1.2 InChI
InChI=1S/C26H24N4O5/c1-27-26-29-20-14-22(34-3)21(33-2)13-19(20)23(30-26)17-6-5-7-18(12-17)28-24(31)15-8-10-16(11-9-15)25(32)35-4/h5-14H,1-4H3,(H,28,31)(H,27,29,30)
2.1.3 InChI Key
BBTFKAOFCSOZMB-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CNC1=NC2=CC(=C(C=C2C(=N1)C3=CC(=CC=C3)NC(=O)C4=CC=C(C=C4)C(=O)OC)OC)OC
2.2 Other Identifiers
2.2.1 UNII
TO043KKB9C
2.3 Synonyms
2.3.1 MeSH Synonyms

1. E6005

2. Methyl 4-(((3-(6,7-dimethoxy-2-(methylamino)quinazolin-4-yl)phenyl)amino)carbonyl)benzoate

3. Rvt-501

2.3.2 Depositor-Supplied Synonyms

1. Lotamilast

2. 947620-48-6

3. E6005

4. E-6005

5. Rvt-501

6. Lotamilast [usan]

7. To043kkb9c

8. Methyl 4-({3-[6,7-dimethoxy-2-(methylamino)quinazolin-4-yl]phenyl}carbamoyl)benzoate

9. (methyl 4-(((3-(6,7-dimethoxy-2-(methylamino)quinazolin-4-yl)phenyl(amino)carbonyl)benzoate

10. Methyl 4-[[3-[6,7-dimethoxy-2-(methylamino)quinazolin-4-yl]phenyl]carbamoyl]benzoate

11. Benzoic Acid, 4-(((3-(6,7-dimethoxy-2-(methylamino)-4-quinazolinyl)phenyl)amino)carbonyl)-, Methyl Ester

12. Unii-to043kkb9c

13. Lotamilast [inn]

14. Lotamilast (usan/inn)

15. Lotamilast [who-dd]

16. Schembl369445

17. Chembl3989967

18. Rvt 501

19. Bcp25249

20. Ex-a1382

21. Xmb62048

22. Bdbm50559709

23. Mfcd28502071

24. Zinc113676839

25. Cs-7517

26. Db12776

27. Sb16962

28. Ac-35466

29. As-52366

30. Hy-12740

31. D11305

32. P14967

33. A901684

34. Q27290049

2.4 Create Date
2008-08-11
3 Chemical and Physical Properties
Molecular Weight 472.5 g/mol
Molecular Formula C26H24N4O5
XLogP34.2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count8
Rotatable Bond Count8
Exact Mass472.17466988 g/mol
Monoisotopic Mass472.17466988 g/mol
Topological Polar Surface Area112 Ų
Heavy Atom Count35
Formal Charge0
Complexity716
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty